Merck Bioprocessing Production Center to be Established in Daejeon, South Korea

2024-06-27

The global healthcare and life sciences company Merck is establishing a bioprocessing production center in the International Science Business Belt located in Daejeon city, South Korea. For this purpose, Merck signed a Memorandum of Understanding (MoU) with the Ministry of Trade, Industry and Energy of Korea and Daejeon Metropolitan City in May 2023.

On May 29, 2024, a groundbreaking ceremony was held for the Merck bioprocessing production center in the International Science Business Belt hub zone in Daejeon. Merck has decided to invest 300 million EUR (430 billion KRW) for the construction of the bioprocessing production center, which will cover an area of 43,000 square meters and is expected to be completed by the end of 2026. This bioprocessing production center will support the entire process from biopharmaceutical development to clinical stages and manufacturing, targeting biopharmaceutical companies throughout the Asia-Pacific region

Source: https://www.hani.co.kr/arti/area/chungcheong/1142519.html